Repligen | RGEN - Cost Of Sales



Repligen reported $91.22M in Cost of Sales for its fiscal quarter ending in June of 2025.


Cost Of Sales Change Date
Agilent USD 850M 48M Jul/2025
Align Technology USD 304.33M 5.18M Jun/2025
Bio Techne USD 118.15M 16.53M Jun/2025
BioMarin Pharmaceutical USD 154.94M 3.38M Jun/2025
Bristol-Myers Squibb USD 3.37B 339M Jun/2025
Bruker USD 439.5M 29.3M Jun/2025
Charles River Laboratories USD 713.98M 47.54M Jun/2025
Danaher USD 2.41B 183M Jun/2025
Dentsply International USD 446M 33M Jun/2025
Exact Sciences USD 248.63M 42.39M Jun/2025
General Electric Aerospace USD 7B 799M Jun/2025
Henry Schein USD 2.29B 120M Jun/2025
Illumina USD 364M 6M Jun/2025
IQVIA Holdings USD 2.97B 439M Jun/2025
Mettler Toledo International USD 403.34M 45.48M Jun/2025
Myriad Genetics USD 61.7M 2M Mar/2025
Pfizer USD 4.99B 2.4B Jun/2025
Repligen USD 91.22M 12.81M Jun/2025
Revvity USD 327.73M 38.51M Jun/2025
Standard Biotools USD 11.13M 13.68M Jun/2025
Thermo Fisher Scientific USD 6.81B 751M Jun/2025
Waters USD 333.31M 56.57M Jun/2025
West Pharmaceutical Services USD 492.6M 26.5M Jun/2025